RECENT ADVANCES IN THE 5Q- SYNDROME

RECENT ADVANCES IN THE 5Q- SYNDROME

The 5q- syndrome is the most distinct of the myelodysplastic syndromes (MDS) and patients with this disorder have a deletion of chromosome 5q [del(5q)] as the sole karyotypic abnormality. Several genes mapping to the commonly deleted region of the 5q- syndrome have been implicated in disease pathoge...

Full description

Bibliographic Details
Main Authors:	Andrea Pellagatti, Jacqueline Boultwood
Format:	Article
Language:	English
Published:	PAGEPress Publications 2015-05-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Myelodysplastc Syndromes, 5q- syndrome, Cytogenetics, Revlimid
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/2286

Similar Items

Non-Requirement to Blood Transfusion in a Patent With Myelodysplastc Syndrome Following the Oral Administraton of β-D-Mannuronic Acid: A Case Report
by: Afshin Ghaderi, et al.
Published: (2019-08-01)

Erythrophagocytosis by neutrophils and megakaryocytic emperipolesis are distinctive morphologic features in del(20q)-associated myelodysplastic syndrome
by: Min Shi, MD, PhD, et al.
Published: (2017-06-01)

Retinoblastoma and mosaic 13q deletion: a case report
by: Pablo Gargallo, et al.
Published: (2021-09-01)

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
by: Anuj Mahindra, et al.
Published: (2010-05-01)

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
by: Paul Richardson, et al.
Published: (2010-05-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

Lenalidomide-related malar rash-like lesion in patient with 5q-syndrome
by: Gokhan Sargin, et al.
Published: (2019-01-01)

Long-Term Response in a Patient with del(5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge
by: Francesco Pisani, et al.
Published: (2014-04-01)

Prenatal genetic diagnosis in a fetus with partial trisomy 18q that inherited from his mother's chromosomal rearrangement
by: Hui Lu, et al.
Published: (2019-10-01)

PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION
by: R. Yagudina, et al.
Published: (2015-03-01)

Features of cytogenetic diagnosis of simultaneous chronic lymphocytic leukemia and myelodysplastic syndrome: clinical case report
by: M. A. Kislitsyna, et al.
Published: (2019-10-01)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
by: Julie Schanz, et al.
Published: (2015-04-01)

Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
by: Pasquale Niscola
Published: (2014-08-01)

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
by: Catherine S. Y. Lecat, et al.
Published: (2021-07-01)

Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation
by: Agarwal, A., et al.
Published: (2022)

Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!
by: Hassan A. Al-Jafar, et al.
Published: (2012-10-01)

The kariotype variability in children with Down syndrome from the Odesa region
by: N. V. Kulbachuk, et al.
Published: (2021-02-01)

Diagnosis of Fragile X Syndrome
by: J Gordon Millichap
Published: (1991-12-01)

Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
by: Antonella Vaccarino, et al.
Published: (2016-10-01)

Cri du chat syndrome: A series of five cases
by: Harsha M Dangare, et al.
Published: (2012-01-01)

Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data
by: Wang N, et al.
Published: (2020-07-01)

Cytogenetic findings at Down syndrome and their correlation with clinical findings
by: Amra Ćatović, et al.
Published: (2005-11-01)

Cytogenetics findings at Turner Syndrome and their correlation with clinical findings
by: Amra Ćatović, et al.
Published: (2005-08-01)

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast
by: Nida Anwar, et al.
Published: (2017-05-01)

Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
by: Sugimoto Yuka, et al.
Published: (2012-03-01)

Comparison of Classical Cytogenetics Versus Interphase FISH in Diagnosis of Mosaic Form of Turner Syndrome
by: Shohreh Shargh, et al.
Published: (2010-11-01)

Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients
by: Mostafa Paridar, et al.
Published: (2021-05-01)

Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (DiGeorge Syndrome) in an Adult
by: Melissa Elise van der Meijs, et al.
Published: (2021-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01)

A case of myelodysplastic syndrome with t(10;18)(q26;q21)
by: Yusuke Ohba, et al.
Published: (2019-10-01)

Cytogenetic and Array-CGH Characterization of a Simple Case of Reciprocal t(3;10) Translocation Reveals a Hidden Deletion at 5q12
by: Angelo Cellamare, et al.
Published: (2021-06-01)

Inconsistency of Karyotyping and Array Comparative Genomic Hybridization (aCGH) in a Mosaic Turner Syndrome Case
by: Pinar Tulay, et al.
Published: (2020-12-01)

Evans syndrome and antibody deficiency: an atypical presentation of chromosome 22q11.2 deletion syndrome
by: Gloria Colarusso, et al.
Published: (2010-06-01)

Down syndrome associated childhood myeloid leukemia with yet unreported acquired chromosomal abnormalities and a new potential adverse marker: dup(1)(q25q44)
by: Faten Moassass, et al.
Published: (2018-03-01)

Turner Syndrome with Isochromosome Xq and Familial Reciprocal Translocation t(4;16)(p15.2;p13.1)
by: Cetin Z, et al.
Published: (2011-01-01)

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations
by: Yan Jiang, et al.
Published: (2021-01-01)

Corticosteroid-resistant Sweet syndrome in the setting of acute myeloid leukemia with monosomy 7 and 5q deletion
by: Fritzlaine C. Roche, MS, et al.
Published: (2020-12-01)

Acute dystonia in a patient with 22q11.2 deletion syndrome
by: Konstantinos Kontoangelos, et al.
Published: (2015-09-01)

Cytogenetic study of down syndrome in Algeria: Report and review
by: Fayza Belmokhtar, et al.
Published: (2016-01-01)

A report on seven fetal cases associated with 15q11‐q13 microdeletion and microduplication
by: Xiuzhu Huang, et al.
Published: (2021-03-01)